Trump’s Top Choices for FDA Could Bolster the ‘Right-to-Try’ Movement
February 6, 2017
WASHINGTON — Advocates of “right-to-try” laws — giving terminally ill patients wider latitude to try experimental treatments that have passed only basic safety tests — are taking another run at it. Senator Ron Johnson of Wisconsin, a Republican, has re-introduced his legislation. More than 40 of his fellow senators, including a few Democrats, have signed on.
Staffers at the Food and Drug Administration have opposed such proposals in the past. Officials there worry that “right to try” is a way of circumventing the agency’s regulatory authority. But this is now President Donald Trump’s Washington.
Sign up for updates straight to your inbox.